Lacosamide Teva

Lacosamide, the active ingredient in Lacosamide Teva, is an anticonvulsant presented as an oral dosage form for oral use. It is employed in the treatment of partial‑onset seizures, typically as adjunctive therapy in patients with epilepsy.

GNH USA supplies Lacosamide Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an antiepileptic drug that acts on neuronal sodium channels to control seizure activity. - Partial‑onset seizures (focal seizures): reduces seizure frequency as adjunctive therapy. - Epilepsy (overall management): contributes to seizure control when combined with other antiepileptic medications. - Refractory focal epilepsy: provides an additional option for patients whose seizures are not adequately controlled by other agents.

Lacosamide may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: mild to moderate stomach upset. - Fatigue: increased tiredness or lack of energy. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Cardiac conduction abnormalities: PR‑interval prolongation or arrhythmia. - Suicidal ideation: emergence of thoughts of self‑harm. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Respiratory depression: marked reduction in breathing effort. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Allergic reactions: anaphylaxis or severe hypersensitivity.

Before initiating therapy, clinicians should evaluate several safety considerations. - Monitor cardiac function: obtain baseline ECG and watch for PR‑interval changes. - Assess renal function: adjust dosing in severe renal impairment. - Avoid abrupt discontinuation: taper under medical supervision to prevent seizure worsening. - Use caution in hepatic disease: monitor liver enzymes regularly. - Pregnancy: risk unknown; weigh benefits against potential fetal risks. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Lacosamide can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine): may lower lacosamide plasma levels. - Concurrent sodium‑channel blockers (e.g., phenytoin): increase risk of CNS depression. - Drugs that prolong PR interval (e.g., verapamil): may exacerbate cardiac conduction delays.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may experience reduced efficacy. - Alcohol: can enhance dizziness and sedation. - Antacids: generally no dose adjustment needed, but monitor symptom control.